Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use HIBERIX safely and effectively. See full prescribing information for HIBERIX.HIBERIX [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] for injection, for intramuscular useInitial U.S. Approval: 2009
Medication labelWhy this: Advisory · dailymed-other
HIBERIX is indicated for active immunization for the prevention of invasive disease caused by Haemophilus influenzae (H. influenzae) type b. HIBERIX is approved for use in children aged 6 weeks through 4 years (prior to fifth birthday).
- generic_name
- haemophilus b conjugate vaccine (tetanus toxoid conjugate)
- brand_name
- sterile water
- product_names
- Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate), sterile water
- ndc
- 58160-818, 58160-818-11, 58160-816, 58160-816-01, 58160-816-05, 58160-817, 58160-817-01, 58160-817-05, 58160-726, 58160-726-15, 58160-816-03, 58160-817-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en